BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 10857176)

  • 1. Specification of potential indications and contraindications of sentinel lymph node biopsy in breast cancer.
    Schlag PM; Bembenek A
    Recent Results Cancer Res; 2000; 157():228-36. PubMed ID: 10857176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Sentinel" lymph node biopsy in breast carcinoma. Current experiences].
    Bembenek A; Kettelhack C; Reuhl T; Markwardt J; Hohenberger P; Schneider U; Schlag PM
    Zentralbl Chir; 2000; 125(10):817-21. PubMed ID: 11098576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node dissection in breast cancer.
    Bembenek A; Reuhl T; Markwardt J; Schneider U; Schlag PM
    Swiss Surg; 1999; 5(5):217-21. PubMed ID: 10546520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
    Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
    J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.
    Feldman SM; Krag DN; McNally RK; Moor BB; Weaver DL; Klein P
    J Am Coll Surg; 1999 Mar; 188(3):248-54. PubMed ID: 10065813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
    Pargaonkar AS; Beissner RS; Snyder S; Speights VO
    Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients.
    Canavese G; Gipponi M; Catturich A; Vecchio C; Tomei D; Nicoló G; Carli F; Spina B; Bonelli L; Villa G; Buffoni F; Bianchi P; Agnese A; Mariani G
    J Surg Oncol; 2001 Jun; 77(2):81-7; discussion 88. PubMed ID: 11398158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow-up. A prospective study into the accuracy of sentinel node biopsy in breast cancer patients.
    Heuts EM; van der Ent FW; Hulsewé KW; Heeren PA; Hoofwijk AG
    Acta Chir Belg; 2007 Jun; 107(3):279-83. PubMed ID: 17685253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
    Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
    Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
    Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
    J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of the sentinel lymph node procedure in patients with large size breast cancer.
    Lelievre L; Houvenaeghel G; Buttarelli M; Brenot-Rossi I; Huiart L; Tallet A; Tarpin C; Jacquemier J
    Ann Surg Oncol; 2007 Feb; 14(2):621-6. PubMed ID: 17103062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer.
    van de Vrande S; Meijer J; Rijnders A; Klinkenbijl JH
    Eur J Surg Oncol; 2009 Mar; 35(3):276-80. PubMed ID: 18786801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
    Soni NK; Spillane AJ
    ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye and intraoperative gamma probe.
    Villa G; Gipponi M; Buffoni F; Vecchio C; Bianchi P; Agnese G; Di Somma C; Catturich A; Rosato F; Tomei D; Nicolò G; Badellino F; Mariani G; Canavese G
    Tumori; 2000; 86(4):297-9. PubMed ID: 11016707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node mapping performed before preoperative chemotherapy may avoid axillary dissection in breast cancer patients with negative or micrometastatic sentinel nodes.
    Schrenk P; Tausch C; Wölfl S; Bogner S; Fridrik M; Wayand W
    Am J Surg; 2008 Aug; 196(2):176-83. PubMed ID: 18513692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.